New 12-Month Preclinical Milestone in Regenerative Aesthetics
Conexeu completed a 12-month multi-tissue preclinical program in aesthetics. The program met its pre-defined objectives.
CXU™ is investigational. Safety and effectiveness have not been established.
HOW BIOREGENERATION WORKS
Tissue regeneration is a coordinated biological process often described through the interplay of cells, biochemical signals, and an ECM structural scaffold environment.
Cells and signals play essential roles, white a scaffold can add a structural component that many current medical aesthetic injectables do not directly supply.
The biological drivers involved in forming and maintaining tissue.
The biochemical messages that help guide cellular behavior.
The structural framework that may help support cells, tissue organization and biological remodeling.
The Evolution of Aesthetics
Each category is designed to address specific aspects of tissue structure or biology. Bioregeneration introduces a different approach, bringing structural support together with the body’s own regenerative processes.
Proposed scaffold-based approach (ECM)
Tissue remodeling
Tissue repair
Biological signaling
Collagen formation
Temporary volume
The design hypothesis is to help organize the tissue environment while endogenous repair and remodeling processes occur.
Proposed approach · Preclinical; not reviewed by the FDA
Influences biological signaling and collagen formation over time.
Exosomes can carry signaling molecules between cells while peptides may act as molecular messengers. There are currently no FDA-approved exosome products; regulatory status and clinical evidence vary by product and intended use.
Provides temporary volume, not a structural scaffold for tissue rebuilding.
WHY IT MATTERS
Tissue structure matters. The extracellular matrix, or ECM, provides part of the frameworkthrough which tissue develops, repairs and remodels. A scaffold is designed toprovide temporary structure while biological activity and tissue interaction occur.
For Conexeu, bioregeneration brings that structural foundation together with four requirements.
Physical structure and volumizing support at the time of placement.
The potential to interact with and become incorporated into the surrounding tissue environment.
An environment that may support tissue remodeling over time.
Structural support designed to provide temporary support and then gradually reabsorb.
While existing injectable categories may satisfy one or more of these requirements, none may meet all four. This unmet need may open the door to a new paradigm in tissue restoration: bioregeneration.
Growing Demand
Aging, injury and significant weight loss may affect more than surface appearance. They can alter volume, structure and tissue quality across the face and body. The growing adoption of GLP-1 medications is reshaping the aesthetics landscape. As more people experience significant weight loss, interest is growing in approaches designed for facial and body tissue restoration at a different scale. This may require more than additional volume. It may require a new way to think about tissue restoration.
The CXU™ Platform
CXU™ is Conexeu’s proprietary extracellular matrix platform.
The platform is designed around a single structural principle: one formula, one device, with the potential to scale across multiple tissue-restoration applications.
See how it works
The structural framework surrounding cells that helps support tissue organization.
A three-dimensional framework designed to provide structure and support for cells and tissue.
Physical support that helps maintain space, shape and stability within tissue.
The process through which a material interacts with and may become incorporated into surrounding tissue.
The process through which cells and tissues reorganize, replace or modify biological structures over time.
The biological restoration or replacement of damaged or lost cells or tissue.
One Platform. Multiple Possibilities.
Defining Bioregeneration
